Latest Advances

  • Condition: Cold Agglutinin Disease
  • Journal: Frontiers in immunology
  • Treatment Used: Daratumumab
  • Number of Patients: NULL
  • Published —
The study researched the effects of daratumumab in patients with cold agglutinin disease.
  • Condition: Autoimmune Cytopenia
  • Journal: Experimental oncology
  • Treatment Used: Various
  • Number of Patients: 83
  • Published —
In this study, researchers sought to determine the best treatment for autoimmune cytopenia due to chronic lymphocytic leukemia.
  • Condition: Relapsed/refractory Autoimmune Cytopenias
  • Journal: Hematology (Amsterdam, Netherlands)
  • Treatment Used: Tacrolimus
  • Number of Patients: 80
  • Published —
In this study, researchers evaluated the outcomes of using tacrolimus for the treatment of relapsed/refractory autoimmune cytopenias.
  • Condition: Autoimmune Hemolytic Anemia
  • Journal: Zhongguo shi yan xue ye xue za zhi
  • Treatment Used: Blood Transfusion and Hormone Therapy
  • Number of Patients: 40
  • Published —
This study tested the safety and efficacy of using a blood transfusion alongside hormone therapy to treat patients with autoimmune hemolytic anemia.
  • Condition: Primary Relapsed/Refractory Autoimmune Cytopenia
  • Journal: Experimental hematology
  • Treatment Used: Sirolimus
  • Number of Patients: 45
  • Published —
This study evaluated the effectiveness and toxicity of sirolimus in patients with primary relapsed/refractory autoimmune cytopenia.
  • Condition: Cold Agglutinin Syndrome
  • Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
  • Treatment Used: Immunosuppressive Therapy
  • Number of Patients: 1
  • Published —
In this study, researchers sought to determine the best treatment for for a man with cold agglutinin syndrome due to rheumatoid arthritis.
  • Condition: Cold Agglutinin Disease (CAD)
  • Journal: Scientific reports
  • Treatment Used: Rituximab-Containing Therapy
  • Number of Patients: 16
  • Published —
This study analyzed the response to rituximab-containing therapy in patients with cold agglutinin disease (CAD), a rare form of autoimmune hemolytic anemia.
  • Condition: Autoimmune Hemolytic Anemia Induced by Salvianolate
  • Journal: Zhongguo shi yan xue ye xue za zhi
  • Treatment Used: Blood Transfusion
  • Number of Patients: 0
  • Published —
This study evaluated the characteristics of autoimmune hemolytic anemia caused by salvianolate.
  • Condition: Relapsed/Refractory Autoimmune Hemolytic Anemia
  • Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • Treatment Used: Ibrutinib
  • Number of Patients: 0
  • Published —
The study researched the safety and effectiveness of ibrutinib for treating relapsed/refractory autoimmune hemolytic anemia.
  • Condition: Autoimmune Hemolytic Anemia
  • Journal: Journal of clinical apheresis
  • Treatment Used: Therapeutic Plasma Exchange
  • Number of Patients: 906
  • Published —
This review of literature evaluated the effectiveness and safety of therapeutic plasma exchange (TPE) for adult patients with autoimmune hemolytic anemia (AIHA).
  • Condition: Cold Agglutinin Disease
  • Journal: Blood advances
  • Treatment Used: Sutimlimab
  • Number of Patients: 7
  • Published —
In this study, researchers evaluated the safety and effectiveness of safety and efficacy of long-term maintenance treatment with sutimlimab in patients with cold agglutinin disease.
  • Condition: Metastatic Melanoma
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Nivolumab and Ipilimumab
  • Number of Patients: 1
  • Published —
This study examined a case of a woman with metastatic melanoma (when the cancer spreads from the tumor to other parts of your body) treated with ipilimumab and nivolumab who developed severe anemia (a low number of red blood cells).
Showing 1-12 of 40